d) at Gilead Sciences

Munich, Bavaria, Germany

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Experience in the pharmaceutical or biotech industry, ideally in commercial training, education, or Sales/Marketing roles
Proven ability to design and deliver impactful training programs for commercial teams. Expertise in blended learning formats (in-person, virtual, and digital)
Strong understanding of omnichannel engagement and high digital literacy, including experience with learning management systems, video authoring tools, and AI applications
Ability to measure learning outcomes, interpret data, and apply insights to optimize programs and drive continuous improvement
Exceptional interpersonal and communication skills, with the ability to engage and influence stakeholders at all levels. Fluency in German and English is essential
Open to new ideas and committed to continuous learning. Passionate about leveraging technology

Responsibilities

Act as a trusted CL&D partner to Commercial teams, identifying learning needs and translating them into effective development solutions. Develop comprehensive training curricula covering disease and product knowledge as well as selling skills in close alignment with marketing campaigns. Drive onboarding, launch readiness, continuous development programs, and change management initiatives
Embed omnichannel engagement principles, digital competencies, and the Gilead Selling Model into learning journeys. Design and implement innovative programs leveraging digital tools, virtual platforms, and interactive methodologies to maximize engagement and impact
Lead the design and delivery of blended learning solutions (face-to-face, virtual, and digital) for Sales and Marketing teams. Represent CL&D in cross-functional and global projects, ensuring alignment with organizational priorities
Establish robust metrics to measure learning effectiveness and business impact. Use data-driven insights to continuously refine programs and drive continuous improvement
Partner with global CL&D teams to adapt and localize global initiatives for the German market. Manage relationships with external training providers and internal regional trainers to ensure high-quality delivery
Champion a culture of innovation by introducing emerging technologies, AI-driven learning tools, and modern content formats. Stay ahead of industry trends to future-proof digital learning capabilities

Skills

Learning & Development

Training Curriculum Design

Omnichannel Engagement

Digital Learning Tools

Selling Skills

Onboarding Programs

Change Management

Strategic Business Partnering

Commercial Training

Leadership Development

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free